Royal Bank Of Canada Vista Gen Therapeutics, Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.12 - $0.3 $2,039 - $5,098	-16,996 Reduced 59.48%	11,578 $1,000
Q4 2022 Feb 14, 2023	BUY	$0.09 - $4.8 $2,358 - $125,774	26,203 Added 1105.15%	28,574 $2,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $4.8 $38 - $1,315	274 Added 13.07%	2,371 $0
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $8,646 - $16,997	-9,825 Reduced 82.41%	2,097 $2,000
Q1 2022 May 16, 2022	SELL	$1.14 - $2.09 $36,088 - $66,163	-31,657 Reduced 72.64%	11,922 $15,000
Q4 2021 Feb 14, 2022	BUY	$1.67 - $2.76 $39,607 - $65,458	23,717 Added 119.41%	43,579 $85,000
Q3 2021 Nov 15, 2021	BUY	$2.62 - $3.45 $17,622 - $23,204	6,726 Added 51.2%	19,862 $55,000
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $25,746 - $41,378	13,136 New	13,136 $41,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.